Written by Reuters | Mumbai |
Published: March 30, 2009 11:20:48 am
Cadila Healthcare said on Monday its Zydus Cadila has signed a collaborative drug discovery and development deal with US-based Eli Lilly to develop drugs for cardiovascular diseases.
Under the deal,Zydus could receive up to $300 million in potential milestone payments and royalties from sales of a drug developed from the collaboration,the Indian firm said in a statement.
📣 The Indian Express is now on Telegram. Click here to join our channel (@indianexpress) and stay updated with the latest headlines
For all the latest Business News, download Indian Express App.
